Detalhe da pesquisa
1.
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Blood
; 142(22): 1871-1878, 2023 11 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37494698
2.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Anticancer Drugs
; 35(1): 63-69, 2024 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37067996
3.
Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
Cancer
; 129(3): 385-392, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36413412
4.
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Blood
; 137(4): 513-523, 2021 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-33507295
5.
MicroRNA and long non-coding RNA analysis in IgM monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.
Haematologica
; 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38058213
6.
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
Am J Hematol
; 98(3): 432-439, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36588384
7.
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
Am J Hematol
; 98(3): 413-420, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36588396
8.
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
Am J Hematol
; 98(8): 1277-1285, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37334773
9.
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
Am J Hematol
; 98(10): 1540-1549, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37421603
10.
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
Am J Hematol
; 98(1): 49-55, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36226510
11.
Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
Br J Haematol
; 199(1): 95-99, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35694818
12.
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series.
Am J Kidney Dis
; 79(2): 202-216, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34175375
13.
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
Am J Hematol
; 97(2): 209-215, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34822175
14.
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
Am J Hematol
; 97(3): 267-273, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34978743
15.
Prognostic significance of acquired 1q22 gain in multiple myeloma.
Am J Hematol
; 97(1): 52-59, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34710241
16.
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
Am J Hematol
; 97(4): 401-410, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35015310
17.
A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis.
Kidney Int
; 99(3): 707-715, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32712168
18.
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
Br J Haematol
; 195(2): 210-216, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34340248
19.
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma.
Br J Haematol
; 193(2): 380-385, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33216966
20.
Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib.
Br J Haematol
; 192(3): 542-550, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33207010